SCHEMBL172247

SCHEMBL172247

CCCN(CCC)C(C)CC

nearest known ligand 0.40

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.40
TSHR P16473 1/20 0.32
KCNA5 P22460 1/20 0.31
KCNH2 Q12809 1/20 0.31
CA1 P00915 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13452916 1.00 FDPS (0.40) FDPSTSHRKCNA5KCNH2CA1
Hydrochloric Acid SCHEMBL22575642 0.97 FDPS (0.39) FDPSTSHRKCNA5KCNH2
Water SCHEMBL27796806 0.97 FDPS (0.39) FDPSTSHRKCNA5KCNH2
SCHEMBL7776790 0.89 FDPS (0.34) FDPSTSHRCA1
SCHEMBL2184102 0.88 FDPS (0.37) FDPSKCNA5
SCHEMBL25469904 0.87 DNM1 (0.40) FDPSTSHRCA1
SCHEMBL13995268 0.87 ALDH1A1 (0.33) FDPS
SCHEMBL7961589 0.87 FDPS (0.38) FDPSTSHR
SCHEMBL3312355 0.85 MMP1 (0.33) FDPSTSHRCA1
SCHEMBL13178779 0.85 MMP1 (0.33) FDPSTSHRCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12372474-B2 Branched-chain amines in electrochemiluminescence detection ROCHE DIAGNOSTICS OPERATIONS, INC. (US) 2025-07-29 US claimed
US-20240044804-A9 BRANCHED-CHAIN AMINES IN ELECTROCHEMILUMINESCENCE DETECTION ROCHE DIAGNOSTICS OPERATIONS, INC. 2024-02-08 US claimed
EP-3426398-B1 BRANCHED-CHAIN AMINES IN ELECTROCHEMILUMINESCENCE DETECTION ROCHE DIAGNOSTICS GMBH (DE) 2024-01-24 EP claimed
CN-108698047-B Branched amines in electrochemiluminescence detection 豪夫迈·罗氏有限公司 2022-04-01 CN claimed
US-20210381987-A1 BRANCHED-CHAIN AMINES IN ELECTROCHEMILUMINESCENCE DETECTION ROCHE DIAGNOSTICS OPERATIONS INC (US) 2021-12-09 US claimed
US-11125695-B2 Branched-chain amines in electrochemiluminescence detection ROCHE DIAGNOSTICS OPERATIONS, INC. 2021-09-21 US claimed
EP-3426398-A1 BRANCHED-CHAIN AMINES IN ELECTROCHEMILUMINESCENCE DETECTION Roche Diagnostics GmbH (DE) 2019-01-16 EP claimed
US-20180364175-A1 BRANCHED-CHAIN AMINES IN ELECTROCHEMILUMINESCENCE DETECTION ROCHE DIAGNOSTICS OPERATIONS, INC. (US) 2018-12-20 US claimed
CN-108698047-A Branched amines in electrochemiluminescence detection 豪夫迈·罗氏有限公司 2018-10-23 CN claimed
WO-2017153574-A1 BRANCHED-CHAIN AMINES IN ELECTROCHEMILUMINESCENCE DETECTION ROCHE DIAGNOSTICS GMBH (DE) 2017-09-14 WO claimed
US-12372474-B2 Branched-chain amines in electrochemiluminescence detection ROCHE DIAGNOSTICS OPERATIONS, INC. (US) 2025-07-29 US disclosed
US-20240044804-A9 BRANCHED-CHAIN AMINES IN ELECTROCHEMILUMINESCENCE DETECTION ROCHE DIAGNOSTICS OPERATIONS, INC. 2024-02-08 US disclosed
EP-3426398-B1 BRANCHED-CHAIN AMINES IN ELECTROCHEMILUMINESCENCE DETECTION ROCHE DIAGNOSTICS GMBH (DE) 2024-01-24 EP disclosed
EP-4119141-A1 NELOTANSERIN FOR THE PROPHYLAXIS AND TREATMENT OF REM SLEEP BEHAVIOR DISORDER Axovant Sciences GmbH (CH) 2023-01-18 EP disclosed
CN-108698047-B Branched amines in electrochemiluminescence detection 豪夫迈·罗氏有限公司 2022-04-01 CN disclosed
CN-1577658-A Driving electrolyte and electrolytic capacitor using the same MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) 2005-02-09 CN disclosed
EP-0838508-B1 Aqueous ink composition for use in an ink-jet printer SEIKO EPSON CORP (JP) 2001-08-29 EP disclosed
US-5871572-A COLORANT, WATER, A WATER-SOLUBLE ORGANIC SOLVENT, AND PECTIC ACID SEIKO EPSON CORPORATION (JP) 1999-02-16 US disclosed
EP-0838508-A2 Aqueous ink composition for use in an ink-jet printer SEIKO EPSON CORPORATION (JP) 1998-04-29 EP disclosed
US-5440034-A Catalytic dehydrocyclization using molecular sieve UOP (US) 1995-08-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180364175-A1 BRANCHED-CHAIN AMINES IN ELECTROCHEMILUMINESCENCE DETECTION BCAT2, BCAT1, MAOB FDPS 3019/4885TSHR 1498/4885KCNA5 1824/4885
US-12372474-B2 Branched-chain amines in electrochemiluminescence detection BCAT2, BCAT1, MAOB FDPS 3296/4885TSHR 1431/4885KCNA5 1851/4885
US-20210381987-A1 BRANCHED-CHAIN AMINES IN ELECTROCHEMILUMINESCENCE DETECTION BCAT2, BCAT1, MAOB FDPS 2939/4885TSHR 1437/4885KCNA5 1612/4885
US-20240044804-A9 BRANCHED-CHAIN AMINES IN ELECTROCHEMILUMINESCENCE DETECTION BCAT2, BCAT1, MAOB FDPS 2939/4885TSHR 1437/4885KCNA5 1612/4885
US-11125695-B2 Branched-chain amines in electrochemiluminescence detection BCAT2, BCAT1, MAOB FDPS 3019/4885TSHR 1498/4885KCNA5 1824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.